Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran

Background: Hip, vertebral and wrist fractures are the most common consequences of osteoporosis. This study aimed at analyzing the cost-effectiveness of teriparatide (CinnoPar®), compared with alendronate and risedronate, in the treatment of women aged 60 and over with postmenopausal osteoporosis in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Med J Islam Repub Iran
Hlavní autoři: Ebadi Fard Azar, Amir Ali, Rezapour, Aziz, Alipour, Vahid, Sarabi-Asiabar, Ali, Gray, Serajaddin, Mobinizadeh, Mohammadreza, Yousefvand, Mani, Arabloo, Jalal
Médium: Artigo
Jazyk:Inglês
Vydáno: Iran University of Medical Sciences 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5804430/
https://ncbi.nlm.nih.gov/pubmed/29445668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14196/mjiri.31.39
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky